Kayne Anderson Rudnick Investment Management LLC decreased its stake in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 0.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,736,557 shares of the business services provider's stock after selling 38,920 shares during the period. Kayne Anderson Rudnick Investment Management LLC owned 9.33% of Exponent worth $422,027,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in EXPO. Private Trust Co. NA lifted its position in shares of Exponent by 129.8% during the fourth quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock worth $25,000 after purchasing an additional 157 shares in the last quarter. Atala Financial Inc bought a new position in Exponent in the 4th quarter worth approximately $25,000. Westside Investment Management Inc. acquired a new position in Exponent during the 3rd quarter worth $26,000. Tortoise Investment Management LLC boosted its position in Exponent by 76.7% in the 4th quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider's stock valued at $39,000 after buying an additional 191 shares during the last quarter. Finally, Trust Co. of Vermont bought a new position in Exponent in the 4th quarter valued at $45,000. Institutional investors own 92.37% of the company's stock.
Exponent Price Performance
Shares of EXPO stock traded down $0.60 on Friday, reaching $78.40. 119,432 shares of the stock were exchanged, compared to its average volume of 244,922. Exponent, Inc. has a one year low of $73.83 and a one year high of $115.75. The stock has a market cap of $3.98 billion, a PE ratio of 37.00 and a beta of 0.84. The stock has a 50 day moving average price of $81.53 and a 200 day moving average price of $91.26.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same quarter in the previous year, the company posted $0.41 earnings per share. On average, research analysts expect that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Exponent news, VP Richard Reiss sold 1,736 shares of the company's stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the completion of the sale, the vice president now owns 1,800 shares in the company, valued at approximately $154,674. The trade was a 49.10 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 2.10% of the stock is currently owned by insiders.
About Exponent
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.